Genmab gibt bekannt, dass Janssen die US-amerikanische FDA-Zulassung für DARZALEX FASPRO® (Daratumumab und Hyaluronidase-fihj) für Patienten mit neu diagnostizierter Leichtketten-(AL)-Amyloidose erhalten hat

  <div class="eh-ribbon">

      Trusted News Since 1995

    <span class="prof not-if-mobile-w820">A service for publishing professionals</span>
    <span class="not-if-mobile-w820">·</span>
    <span class="date">Friday, January 15, 2021</span>
    <span class="not-if-mobile-w430">
      ·
      <a class="article_live_counter" href="/de/live_feed">534,591,441</a>
      Articles
    </span>
    <span class="not-if-mobile-w550">
      ·
      3+ Million Readers
    </span>
  </div>
</header>

<footer>
  <div class="sitemap">
    <h2 class="subheading-osc g_roboto">News Monitoring and Press Release Distribution Tools</h2>
    <div class="row-fluid">
      <div class="span3">
        <section>
          <h3>News Topics</h3>

        </section>
        <section>
          <h3>Newsletters</h3>

        </section>
      </div>
      <div class="span3">
        <section>
          <h3>Press Releases</h3>

        </section>
        <section>
          <h3>Events & Conferences</h3>

        </section>
      </div>
      <div class="span3">
        <section>
          <h3>RSS Feeds</h3>

        </section>
        <section>
          <h3>Other Services</h3>

        </section>
      </div>
      <div class="span3">
        <section>
          <h3>Questions?</h3>

        </section>
        <br/><section>

        </section>
      </div>
    </div>
  </div>
</footer>









<!--[if lt IE 9]>
<script src="https://europeantimes.b-cdn.net/js/excanvas.min.js" type="text/javascript"></script>
<![endif]-->



<!-- Start Alexa Certify Javascript -->

<noscript/>
<!-- End Alexa Certify Javascript -->
<!--[if IE 7]>
<script type="text/javascript" src="https://europeantimes.b-cdn.net/js/json2.js"></script>
<![endif]-->